Back to News
Market Impact: 0.35

Pagaya: This AI Antithesis Might Be Undervalued (Rating Upgrade)

Artificial IntelligenceFintechCompany FundamentalsManagement & GovernanceCorporate Earnings

Pagaya Technologies is being criticized for overstating its AI-driven underwriting capabilities, raising credibility and business model sustainability concerns. While the company’s risk posture has improved, its profitability track record is still too short to be treated as true through-the-cycle evidence. Retained investments and a large credit-loss allowance remain key risks despite recent improvement.

Analysis

This is less a story about model quality than about funding durability. Once a lender’s differentiation is perceived as marketing rather than underwriting edge, the market typically compresses the multiple on two fronts: lower confidence in originations growth and a higher discount rate applied to the retained book. That combination is especially punitive for a platform that still relies on the market believing its capital-light facade while carrying meaningful balance-sheet exposure underneath.

The second-order risk is that improving credit metrics can mask the fact that the portfolio is still young and untested through a full consumer slowdown. If macro data deteriorate over the next 2-3 quarters, any reserve adequacy debate will shift from “credit normalized” to “losses were only delayed,” which tends to trigger abrupt de-rating rather than gradual multiple erosion. Competitors with cleaner pass-through economics or lower retained exposure should gain relative favor as capital allocators rotate away from story stocks toward more transparent credit platforms.

The bear case can re-rate faster than fundamentals if management loses credibility on any forward metric: take-rate, loss assumptions, or book-value sensitivity. That creates a path where the stock trades more like a levered credit vehicle than an AI fintech narrative, which implies much lower tolerance for any reserve misses or guidance resets over the next earnings cycle. The biggest near-term catalyst is not absolute credit deterioration, but proof that the underwriting “edge” is not translating into durable through-cycle excess returns.

Contrarianly, the move may be only partially priced if investors are still valuing the company off top-line automation optics rather than normalized earnings power. If management can demonstrate sustained reserve releases, lower funding costs, and consistent vintage performance through the next two reporting periods, the short thesis loses some immediacy. But until there is a full-cycle track record, the asymmetry still favors skepticism over extrapolation.